Early treatment with JNJ-46356479, a mGluR2 modulator, improves behavioral and neuropathological deficits in a postnatal ketamine mouse model of schizophrenia
| Autor: | Martínez-Pinteño, A., Rodríguez, N., Olivares, D., Madero, S., Gómez, M., Prohens, L., García-Rizo, C., Mas, S., Morén, C., Parellada, E., Gassó, P. |
|---|---|
| Zdroj: | In Biomedicine & Pharmacotherapy February 2023 158 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect